| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |